'Seeing through a glass darkly': Casting light on imidazoline 'I' sites

Trends in Pharmacological Sciences

Volumn 19, Issue 9, 1998, Pages 381-390

  Eglen, Richard M ^a   Hudson, Alan L ^b   Kendall, David A ^d   Nutt, David J ^b   Morgan, Noel G ^c   Wilson, Vince G ^d   Dillon, Michael P ^a  

^a ROCHE BIOSCIENCE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 IMIDAZOLIN 2 YL)QUINOLINE; 2 (2 IMIDAZOLIN 2 YL)QUINOXALINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; AGMATINE; AMINE OXIDASE (FLAVIN CONTAINING); APRACLONIDINE; BRIMONIDINE; CLONIDINE; EFAROXAN; IDAZOXAN; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE; OXYMETAZOLINE; PHENTOLAMINE; RECEPTOR BLOCKING AGENT; RILMENIDINE;

AGONIST; ANIMAL EXPERIMENT; BINDING SITE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG STRUCTURE; INSULIN RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; AGMATINE; ALLOSTERIC SITE; ANIMALS; BINDING, COMPETITIVE; BRAIN; CLONIDINE; DOWN-REGULATION; IMIDAZOLES; KIDNEY; MONOAMINE OXIDASE; NEUROPROTECTIVE AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031692835     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(98)01244-9     Document Type: Review

References (89)

1. Ruffolo J. R., Waddell J. E. W. Br. J. Pharmacol. 77:1982;169-176.
2. Ernsberger P., Meely M. P., Mann J. J., Reis D. J. Eur. J. Pharmacol. 134:1987;1-13.
3. Parini A.et al. Trends Pharmacol. Sci. 17:1996;13-16.
4. Molderings G. J. Drugs Future. 22:1997;757-772.
5. Regunathan S., Reis D. J. Annu. Rev. Pharmacol. Toxicol. 36:1996;511-544.
6. Morgan N. G., Chan S. L. F., Brown C. A., Tsoli E. Ann. New York Acad. Sci. 763:1995;361-373.
7. Head G. A. Ann. New York Acad. Sci. 763:1995;531-540.
8. Dubar M., Pillon G. Ann. New York Acad. Sci. 763:1995;642-658.
9. Chalmers J., Pulowsky P. J. Hypertens. 9:1991;675-694.
10. Ruiz-Ortega J. A., Vgedo L. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;121-126.
11. Docherty J. R., Gothert M., Dieckhofer C., Starke K. Arzneim.-Forsch. Drug Res. 32:1982;1534-1540.
12. Jasper J. R.et al. Biochem. Pharmacol. 55(7):1998;1035-1043.
13. MacPhee G. J. A., Howie C. A., Elliot H. L., Reid J. L. Br. J. Clin. Pharmacol. 33:1992;261-267.
14. Reid J. L. Br. J. Clin. Pharmacol. 42:1996;37-41.
15. Hieble J. P., Kolpak D. C. Br. J. Pharmacol. 110:1993;1635-1639.
16. Urban R. B., Szabo B., Starke K. J. Pharmacol. Exp. Ther. 270:1994;572-578.
17. Urban R. B., Szabo B., Starke K. J. Eur. J. Pharmacol. 282:1995;19-28.
18. Zhu Q-M.et al. Br. J. Pharmacol. 122:1997;70P.
19. Guyenet P. G. Am. J. Physiol. 273:1997;R1580-R1584.
20. Smyth D. D., Penner S. B. J. Cardiovasc. Pharmacol. 26(Suppl. 2):1995;63-67.
21. Sugrue M. F. J. Med. Chem. 40:1997;2793-2809.
22. Lumor I.et al. J. Biol. Chem. 267:1992;216445-216449.
23. Ogidigben M., Chu T-C., Potter D. E. J. Pharmacol. Exp. Ther. 264:1994;172-182.
24. Campbell W. R., Potter D. E. Ann. New York Acad. Sci. 763:1995;463-485.
25. Chu T-C.et al. J. Ocul. Pharmacol. Ther. 13:1997;489-496.
26. Maiese K., Pek L., Berger S. B., Reis D. J. J. Cereb. Blood Flow Metab. 12:1992;53-63.
27. Gustafson I., Westerberg E., Wieloch T. J. Cereb. Blood Flow Metab. 10:1990;885-894.
28. Liu L., Coupar I. M. J. Pharmacol. Exp. Ther. 283:1997;1367-1374.
29. Lione L., Nutt D., Hudson A. Eur. J. Pharmacol. 304:1996;221-229.
30. Hosseini A. R., King P. R., Louis W. J., Gundlach A. L. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;131-138.
31. MacKinnon A. C., Redfern W. S., Brown C. M. Br. J. Pharmacol. 116:1995;1729-1736.
32. Raddatz R., Parini A., Lanier S. M. Mol. Pharmacol. 52:1997;549-553.
33. Raddatz R., Lanier S. M. Neurochem. Int. 30:1997;109-117.
34. Carpéné C.et al. J. Pharmacol. Exp. Ther. 272:1995;681-688.
35. Olmos G., Gabilondo A. M., Miralles A., Escribá P. A., Garcia-Sevilla J. A. Br. J. Pharmacol. 108:1993;597-603.
36. Lalies M. D., Nutt D. J., Hudson A. L. Br. J. Pharmacol. 112:1997;67P.
37. Gargalidis-Moudanos C., Remaury A., Pizzinat N., Parini A. Mol. Pharmacol. 51:1997;637-643.
38. Escribá P. V.et al. Br. J. Pharmacol. 118:1996;2029-2036.
39. Sastre M., Escribá P. V., Reis D. J., García-Sevilla J. A. Ann. New York Acad. Sci. 763:1995;520-522.
40. Reynolds G. P., Boulton R. M., Pearson S. J., Hudson A. L., Nutt D. J. Eur. J. Pharmacol. 301:1996;R19-R21.
41. Sastre M., Ventayol P., García-Sevilla J. A. NeuroReport. 7:1996;509-512.
42. Nutt D. J., Lalies M. D., Lione L. A., Hudson A. L. J. Psychopharmacol. 11:1997;163-168.
43. Nutt D. J.et al. Ann. New York Acad. Sci. 763:1995;125-140.
44. Diaz A., Mayet S., Dickenson A. H. Eur. J. Pharmacol. 333:1997;9-15.
45. Houghton A. K., Westlund K. N. NeuroReport. 7:1996;1497-1501.
46. Kolesnikov Y., Jain S., Pasternak G. W. Eur. J. Pharmacol. 296:1996;17-22.
47. Brown C. M.et al. Br. J. Pharmacol. 116:1995;1737-1744.
48. Jackson, H. C. and Nutt, D. J. (1996) in Drug Receptor Subtypes and Ingestive Behaviour (Cooper, S. J. and Clifton, P. G., eds), pp. 267-283, Academic Press.
49. Chan S. L. F. Clin. Sci. 85:1993;671-677.
50. Chan S. L. F., Brown C. A., Scarpello K. E., Morgan N. G. Br. J. Pharmacol. 112:1994;1065-1070.
51. Ishida-Takahashi A.et al. Br. J. Pharmacol. 117:1996;1749-1755.
52. Rustenbeck I., Herrmann C., Ratzka P., Hasselblatt A. Naunyn Schmiedeberg's Arch. Pharmacol. 356:1997;410-417.
53. Olmos G., Kulkarni R. N., Haque M., MacDermott J. Eur. J. Pharmacol. 262:1994;41-48.
54. Proks P., Ashcroft F. M. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11716-11720.
55. Chan S. L. F., Cable H. C., Morgan N. G. Pharmacol. Commun. 7:1995;29-41.
56. Mourtada M., Smith S. A., Morgan N. G. Biochem. Biophys. Res. Commun. 236:1997;162-166.
57. Ronner P., Matschinsky F. M., Hang T. L., Epstein A. J., Buettger C. Diabetes. 42:1993;1760-1772.
58. Zaitsev S. V.et al. Diabetes. 45:1996;1610-1618.
59. Olmos G., Ribera J., Garcia-Sevilla J. A. Eur. J. Pharmacol. 310:1996;273-276.
60. Chan S. L. F., Pallett A. L., Clews J., Ramsden C. A., Morgan N. G. Eur. J. Pharmacol. 323:1997;241-244.
61. Le Brigand L.et al. Br. J. Pharmacol. 122:1997;786-791.
62. Chan S. L. F., Atlas D., James R. F. L., Morgan N. G. Br. J. Pharmacol. 120:1997;926-932.
63. Atlas D., Burstein Y. Eur. J. Biochem. 144:1984;287-293.
64. Diamant S., Atlas D. Biochem. Biophys. Res. Commun. 134:1986;184-190.
65. Diamant S., Eldor A., Atlas D. Eur. J. Pharmacol. 144:1987;247-255.
66. Meeley M. P., Ernsberger P., Granata A. R., Reis D. J. Life Sci. 38:1986;1119-1126.
67. Regunathan S., Meeley M. P., Ries D. J. Mol. Pharmacol. 40:1991;884-888.
68. Meeley M. P., Hensley M. L., Ernsberger P., Felsen D., Reis D. J. Biochem. Pharmacol. 44:1992;733-740.
69. Felsen D.et al. J. Pharmacol. Exp. Ther. 268:1994;1063-1071.
70. Atlas D. Biochem. Pharmacol. 41:1991;1541-1549.
71. Atlas D. Science. 266:1995;462-464.
72. Bousquet P., Feldman J., Atlas D. J. Cardiovasc. Pharmacol. 10(Suppl. 12):1987;161-167.
73. Regunathan S., Youngson C., Raasch W., Wang H., Reis D. J. J. Pharmacol. Exp. Ther. 276:1996;1272-1282.
74. Piletz J. E., Zhu H., Chikkala D. N. J. Pharmacol. Exp. Ther. 279:1996;694-702.
75. Hudson A. L.et al. Neurochem. Int. 30:1997;47-53.
76. Alemany R.et al. Eur. J. Pharmacol. 280:1995;205-210.
77. Milligan C. M., MacKinnon A. C. Drug News Perspect. 10:1997;74-84.
78. Li G.et al. Science. 263:1994;966-969.
79. Regunathan S., Meeley M. P., Ries D. J. Mol. Pharmacol. 40:1991;884-888.
80. Separovic D., Kester M., Ernsberger P. Mol. Pharmacol. 49:1996;668-675.
81. Piletz J. E., Chikkala D. N., Ernsberger P. J. Pharmacol. Exp. Ther. 272:1995;581-587.
82. Pinthong D.et al. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;10-61.
83. Reis D. J., Li G., Regunathan S. Ann. New York Acad. Sci. 703:1995;295-313.
84. Head G. A., Chan C. K. S., Cowan S. J. Neurochem. Int. 30:1996;37-45.
85. Regunathan S., Youngson C., Raasch W., Wang H., Reis D. J. J. Pharmacol. Exp. Ther. 276:1996;1272-1282.
86. Chan S. L. F., Cable H. C., Morgan N. G. Pharmacol. Commun. 7:1995;29-41.
87. Chan S. L. F., Atlas D., James R. F. L., Morgan N. G. Br. J. Pharmacol. 120:1997;926-932.
88. Szabo B., Urban R., Limberger N., Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;268-273.
89. Dale H., Laidlaw P. P. J. Physiol. 43:1911;182-195.